课题基金 / 基金详情

Fracture risk of sodium-glucose co-transporter 2 inhibitor therapy in high-risk older adults: population-based studies to establish comparative safety

Fracture risk of sodium-glucose co-transporter 2 inhibitor therapy in high-risk older adults: population-based studies to establish comparative safety
高危老年人钠-葡萄糖协同转运蛋白 2 抑制剂治疗的骨折风险：基于人群的研究以确定相对安全性
批准号：
440882
负责人：
Hayes Kaleen N
金额：
$7.29万
依托单位：
The Brigham and Women's Hospital, Inc. (Boston)
依托单位国家：
加拿大
项目类别：
Fellowship Programs
财政年份：
2020
资助国家：
加拿大
项目状态：
已结题
起止时间：
2020-12-01 至 2022-12-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=440882&lang=en
关键词：
Aging Bone Strength Comparative Drug Safety Diabetes Mellitus Drug Safety Fracture Osteoporosis Pharmacoepidemiology Pharmacovigilance Sodium-Glucose Transporter 2 Inhibitors

项目摘要

项目成果

Hayes Kaleen N的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Type 2 diabetes (T2DM) is a chronic condition of high blood sugar that affects 10% of Canadians and can cause numerous complications when not managed, including major cardiovascular events like stroke. Fractures are also a complication of T2DM- even with
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Investigation of Gastrointestinal Adverse Events of Brand Versus Generic Osteoporosis Medications: Merits and Limitations of Different Non-Experimental Research Methods
  • 批准号：
    404054
  • 项目类别：
    Studentship Programs
  • 资助金额：
    $7.65万
  • 财政年份：
    2018
  • 负责人：
    Hayes Kaleen N
  • 依托单位：
    University of Toronto
海外基金